Evidence map›Paper›PMID 25089266›Full record

ReviewBioMed research international2014

Therapeutically targeting neuroinflammation and microglia after acute ischemic stroke.

Youngjeon Lee, Sang-Rae Lee, Sung S Choi, Hyeon-Gu Yeo, Kyu-Tae Chang, Hong J Lee

Abstract readReview
In one paragraph

Review in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Function of GSK‑3 signaling in spinal cord injury (Review).Experimental and therapeutic medicine · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Knockout of the P2YInternational journal of molecular sciences · 2022
    Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Youngjeon LeeNational Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang 363-883, Republic of Korea.ORCID 0000-0002-5387-3441
Sang-Rae LeeNational Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang 363-883, Republic of Korea.
Sung S ChoiMedical Research Institute, Chung-Ang University College of Medicine, Seoul 156-756, Republic of Korea.
Hyeon-Gu YeoNational Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang 363-883, Republic of Korea.ORCID 0000-0002-6600-6291
Kyu-Tae ChangNational Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang 363-883, Republic of Korea.
Hong J LeeMedical Research Institute, Chung-Ang University College of Medicine, Seoul 156-756, Republic of Korea.ORCID 0000-0003-2641-6437

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation has a pivotal role in the pathogenesis of ischemic stroke, and recent studies posit that inflammation acts as a double-edged sword, not only detrimentally augmenting secondary injury, but also potentially promoting recovery. An initial event of inflammation in ischemic stroke is the activation of microglia, leading to production of both pro- and anti-inflammatory mediators acting through multiple receptor signaling pathways. In this review, we discuss the role of microglial mediators in acute ischemic stroke and elaborate on preclinical and clinical studies focused on microglia in stroke models. Understanding how microglia can lead to both pro- and anti-inflammatory responses may be essential to implement therapeutic strategies using immunomodulatory interventions in ischemic stroke.

Indexed as

AnimalsAnti-Inflammatory AgentsBrain IschemiaCytokinesHumansInflammationInflammation MediatorsMicrogliaPhenotypeSignal TransductionStrokeAnti-Inflammatory AgentsCytokinesInflammation Mediators

Identifiers

PMID25089266
PMCPMC4095830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.